Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects

By Ayalasomayajula Surya P.   Dole Kiran   He Yan-Ling   Ligueros-Saylan Monica   Wang Yibin   Campestrini Joelle   Humbert Henri   Sunkara Gangadhar  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 2913-2920

Informa Healthcare

Access to resources Recommend Favorite

A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects

By Vaidyanathan Sujata   Maboudian Mojdeh   Warren Vance   Yeh Ching-Ming   Dieterich Hans Armin   Howard Dan   Dole William P.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2313-2326

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects

By Sunkara Gangadhar   Reynolds Christine V.   Pommier Francoise   Humbert Henri   Yeh ChingMing   Prasad Pratapa  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 631-640

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1109-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single‐dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK‐1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 400-408

John Wiley & Sons Inc

Access to resources Recommend Favorite